← Back to Search

Behavioral Intervention

Mobile Health Smoking Cessation for Quitting Smoking (PROMOTE-UP Trial)

N/A
Recruiting
Led By Ramzi Salloum, PhD
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
≥21 years old
Be older than 18 years old
Must not have
Unstable medical or psychiatric illness
Timeline
Screening 3 weeks
Treatment Varies
Follow Up months 6 and 12
Awards & highlights

Summary

This trial tests 3 methods to help smokers quit: a mobile app, a mobile app + support, and a quit line.

Who is the study for?
This trial is for individuals over 21 who smoke and want to quit. They must have daily access to a smartphone, be referred by their primary care provider, and receive care at a participating clinic. People with unstable medical or psychiatric conditions cannot join.
What is being tested?
The study compares three smoking cessation methods: the iCanQuit mobile app, iCanQuit combined with another app called Motiv8, and the Florida quit line service. It aims to find out which is most effective in helping underserved patients stop smoking.
What are the potential side effects?
Since this trial involves behavioral interventions like apps and counseling services rather than medications, there are no direct side effects as you would expect from drugs; however, participants may experience stress or frustration during the quitting process.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 21 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not have any unstable medical or mental health conditions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~months 6 and 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and months 6 and 12 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Smoking Point-Prevalence Abstinence (PPA)
Secondary study objectives
Acceptance
Motivation
Quality of Life and Well-Being
+4 more

Trial Design

3Treatment groups
Active Control
Group I: iCanQuit+Motiv8Active Control1 Intervention
Motiv8 is an internet-and smart phone-based contingency management (CM) intervention. Motiv8 verifies smoking status via a hand-held breath carbon monoxide (CO) monitor that is connected to a smart phone. For patients randomized to the iCanQuit+Motiv8 arm (444 total), research staff will assist in downloading the combined pp and connecting the iCO to the patient's phone. Smokers will also be asked to complete the first 4 iCanQuit modules, which contain exercises designed to prepare the users for their quit day. The end of the preparation phase will also mark each patient's quit date. During the intervention (7 weeks), participants will be considered abstinent from smoking if their breath CO sample is ≤ 5 ppm or if the CO value has decreased by 5% per hour from the last sample provided.
Group II: Florida quit lineActive Control1 Intervention
The Florida quit line provides telephone counseling for smoking cessation. Patients randomized to the Florida quit line arm (444 total) will be enrolled after contact information is sent electronically.
Group III: iCanQuitActive Control1 Intervention
iCanQuit is a modern, cognitive behavioral treatment which promotes cessation through greater acceptance of triggers for smoking and commitment to personal values. It is a smart phone-based acceptance and commitment therapy (ACT). For patients randomized to the iCanQuit arm (444 total), research staff will assist in downloading the app onto the patient's phone.

Find a Location

Who is running the clinical trial?

University of FloridaLead Sponsor
1,380 Previous Clinical Trials
761,063 Total Patients Enrolled
Patient-Centered Outcomes Research InstituteOTHER
568 Previous Clinical Trials
27,248,077 Total Patients Enrolled
Ramzi Salloum, PhDPrincipal InvestigatorUniversity of Florida
5 Previous Clinical Trials
1,860 Total Patients Enrolled

Media Library

Florida quit line (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05415761 — N/A
Quitting Smoking Research Study Groups: iCanQuit+Motiv8, Florida quit line, iCanQuit
Quitting Smoking Clinical Trial 2023: Florida quit line Highlights & Side Effects. Trial Name: NCT05415761 — N/A
Florida quit line (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05415761 — N/A
~756 spots leftby Jun 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top